Life Science Investing Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference
Life Science Investing Universal Ibogaine Advises of Departure of Marilyn Loewen Mauritz from the Board of Directors
Life Science Investing Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
Life Science Investing UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS
Life Science Investing Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th
Life Science Investing Life Sciences Virtual Investor Conference: Company Executives Present Live March 10th
Life Science Investing Universal Ibogaine Signs Memorandum of Understanding with the Osoyoos Indian Band
Life Science Investing UNIVERSAL IBOGAINE COMMENCES DEVELOPMENT PLAN AT KELBURN IN PREPARATION FOR IBOGAINE TREATMENTS AND PROVIDES UPDATE ON DRUG SUPPLY
Life Science Investing Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities
Cyprium Metals: Advancing Western Australia’s Nifty Copper Mine for Near-term Production, Long-term Growth
Pinnacle Samples up to 12.2 g/t Gold Equivalent and Commences Field Work at El Potrero Gold-Silver Project
